ERGIC2 Polyclonal Antibody

ERGIC2 Polyclonal Antibody

The ERGIC2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of ERGIC2 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques, resulting in a high affinity and specificity towards ERGIC2.

The ERGIC2 protein, also known as Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 2, plays a crucial role in the organization and function of the early secretory pathway. It is primarily localized in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) and is involved in the transport of cargo proteins from the ER to the Golgi apparatus.

The ERGIC2 Polyclonal Antibody exhibits exceptional sensitivity and selectivity, making it an ideal choice for various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated for its performance in detecting ERGIC2 protein expression in a wide range of species, including human, mouse, and rat.

This antibody is produced using high-quality materials and undergoes rigorous quality control measures to ensure consistent and reliable results. It has been extensively tested for its specificity, ensuring minimal cross-reactivity with other proteins, thus providing accurate and precise data.

The ERGIC2 Polyclonal Antibody is supplied as a liquid formulation, ready to use for immediate application. It is provided in a convenient size, allowing for multiple experiments without compromising its quality. The antibody is stored at the recommended temperature to maintain its stability and functionality.

In summary, the ERGIC2 Polyclonal Antibody is a valuable tool for researchers and scientists studying the ERGIC2 protein and its role in cellular processes. With its exceptional sensitivity, specificity, and reliability, this antibody enables accurate detection and analysis of ERGIC2 expression, contributing to a deeper understanding of cellular mechanisms and potential therapeutic targets.